WHO ICTRP trial
Phase III study of BK1601 in Japanese pediatric subjects
JPRN-jRCT2080225149 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-jRCT2080225149 |
|---|---|
| Public title | Phase III study of BK1601 in Japanese pediatric subjects |
| Scientific title | A observer-blind, active-controlled, multi-center, phase III, comparative study of the efficacy and safety of BK1601 and MR vaccine in Japanese pediatric subjects aged from 5 years to 7 years old. |
| Primary sponsor | The Research Foundation for Microbial Diseases of Osaka University |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 3 |
| Countries | Japan |
| Conditions | Prevention of measles and rubella |
| Interventions | investigational material(s) Generic name etc : BK1601 INN of investigational material : - Therapeutic category code : 636 Mixed biological preparations Dosage and Administration for Investigational material : Product is dissolved with 0.7… |
| Registration date | Jan 4, 2020 |
| Target size | 120 |
| Secondary IDs | JapicCTI-205245 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: